The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients.
about
Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial.Spinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN Study): Protocol of An Exploratory Study In Assessing the Safety and Efficacy of NeuroAiD Amongst People Who Sustain Severe Spinal Cord Injury
P2860
The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients.
@ast
The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients.
@en
type
label
The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients.
@ast
The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients.
@en
prefLabel
The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients.
@ast
The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients.
@en
P2093
P2860
P356
P1476
The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients.
@en
P2093
Alejandro C Baroque Ii
Johnny K Lokin
Jose C Navarro
Mark C Molina
P2860
P304
P356
10.1155/2012/506387
P577
2012-12-13T00:00:00Z